[ad_1]
Drug Carcinog of High Blood Pressure is also taken
There is growing mistrust of Chinese medicines.
According to the South China Morning Post, a Chinese pharmacopoeial company has been involved in the processing of data on rabbit vaccines for human use, following the controversy that the drug 'valsartan & # 39; The agency said that Changchun ChangSung Life Sciences seriously violated the quality control standard (GMP) of pharmaceutical manufacturing, including handling the production record of the "Vero-cell" rabies vaccine for human use.
The GMP certification for the production of rabies vaccines was immediately revoked and the production and sale of the product was prohibited. However, he did not disclose the details of the data manipulation.
Changchun ChangSung is second in the rabies vaccine market in China with a market share of 23%. Last year, only 35.4 million anti-rabies vaccines were produced. Last year, sales of rabies vaccines reached 734 million yuan (about 123 million won), accounting for 47 percent of the company's total sales.
Changchun Changsung said: "I immediately stopped using the existing rabies vaccine in the national drug companies and informed me to keep the vaccine in its current state." "Fortunately, the rabies vaccine, which has been a problem this time, is not yet available on the market, so it can be controlled." Changchun Changsung suffered from the discomfort that DTP vaccines (diphtheria, tetanus and whooping cough) failed to meet quality standards last year.
There has been controversy over the detection of carcinogens in Chinese blood pressure drugs. The European Medicines Agency (EMA) discovered the 'N-nitroso dimethyl amine (NDMA) & # 39; May 5, a substance that could cause cancer in the pharmaceutical raw material valsartan, manufactured by the Chinese pharmaceutical paper manufacturer Nanhai Hai. 28 countries including Korea stopped selling the product and started collecting the product. In China, it was revealed that the vaccine, which expired in 2016 or was stored in the wrong way, was sold for several years.
Beijing: Kang Dong Kyun [email protected]
prohibiting Han Kyung dot com, prohibition of reprinting and redistribution
Source link
